Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. Australian finance news, stock quotes, currency information and blogs0. ASX - Day Trading. ASX - Short Term Trading. ASX - By Stock. . Invex Receives Approval for Paediatric Plan from the EMA, page-2. . Both approaches can work, but it is not wise to confuse the two. Notice of Quarterly Investor Call. Join the HotCopper ASX share market forum today for free. Created with Sketch. Invex Receives Approval for Paediatric Plan from the EMA, page-3. ASX - Short Term Trading. Join the HotCopper ASX share market forum today for free. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. Share 14 mill MC 22 mill cash Like I said they might have gotten rid of Jason and Alex to streamline costs, smartest thing to do is JV with some large pharma let them run trials we get 40% royalty and they get 60% of drug (sell it to them). Created with Sketch. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. Forums. Very impressive. IXC Valuation Report MST. We are a team of expert financial advisers each specialising in different, yet complementary areas. 026. Notification of cessation of securities - IXC. Forums. Release Date: 21/11/22 08:18; Summary: First Patient Randomised in IIH EVOLVE Phase III Trial; Price Sensitive: Yes; Download Document 205. , page-2. . 4KB OECCreated with Sketch. . 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. IXC below Example of that is NEUInvestor Presentation, page-3. Created with Sketch. Withdrawal of AGM ResolutionsInvex Granted Key European Patent for Exenatidehe’s known for the vend etc like asxcowboy has pointed out. ASX - Day Trading. 0. ASX - Day TradingIXC: 22/11/2023 1:08 PM : Notification of cessation of securities - IXC 4 pages 23. 0¢ Sentiment: Buy Disclosure: Held. IXC Price at posting: 38. Learn how it impacts everything we do. Share I've got no issues with it. 375,000. . . Also took placement stock @$1. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. 0. 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. rights. ASX - By Stock. Created with Sketch. 0. IXC Price at posting: 45. ASX - Day Trading. Information. Latest Posts. Created with Sketch. IXC – iShares Global Energy ETF – Check IXC price, review total assets, see historical growth, and review the. Created with Sketch. ASX - Day TradingSomeone bought $500 stock today at 44 cents. Created with Sketch. My understanding is that NEU went from around $1. I find this very intriguing and positive that in last few weeks about 1. Transparency is our policy. When can we expect some update or. 0% $ODM 35. Created with Sketch. 7% #asx #ausbiz 23 Jun 2023 06:06:11. Charts. 40. 3¢. . In the LinkedIn About section for IXC, they list IIH, Acute Stroke and Traumatic Brain Injury. Created with Sketch. . Ionic Rare Earths Limited is an Australia-based company that is focused on investment in. Advertise on HotCopper. To work out how much Presendin is worth, we can look at the costs of IIH to the American health care system. 1950. LoginJoin Now. . Trading HaltIXC Valuation Report MST. Chairman's Address to Shareholders and PresentationHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Mernova, a subsidiary of Melodiol Global Health (ASX:ME1), is on track to achieve its highest ever monthly sales, with revenues expected to reach A$891,944 in October 2023. Market . ASX - General. . ASX - By Stock. Latest Posts. 1950. AVALANCHE. Withdrawal of AGM Resolutions, page-2. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. **Close price adjusted for splits and dividend and/or capital gain distributions. 0 Million. ASX - Short Term Trading. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. no point selling now. Created with Sketch. ASX - Short Term Trading. STN Saturn Metals reports high-grade gold intersections and visible gold at Apollo Hill, WAInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - Day Trading. I'm talking about the period of the announcement about trials None of them moved apart from retailers that hosed out over 3 mill in shares. ASX - Day Tradingis invex releasing 2. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. Created with Sketch. In 2005, IIH cost the American health care. Share No great change in the top 2 big boys who hold 17% of the company, Twiggy's fund unchanged. ASX - Day TradingCreated with Sketch. Created with Sketch. . , page-5. Created with Sketch. 5¢ Sentiment: Buy Disclosure: Held Ive compared IXC to NEU before and believe we approx. Advertise. Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. Investor PresentationI would be worried about holding IXC if they had no more cash. Forums. . Market . 40 in May 2020 and has only fallen over the subsequent 36 months. 59). Forums. Join the HotCopper ASX share market forum today for free. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - Day Trading. ASX - Day TradingInitial FDA and EMA Advice on Presendin Development, page-2. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportA new thread to put trading comments / reasoning / opinions in. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Join the HotCopper ASX share market. 0. , page-3. Below is the broker data for IXC November to. ASX - By Stock. This is fantastic news and I appreciate the fact that it has not been heavily hyped by the company, makes you wonder what else is being worked on. It certainly has been a hard few months for the biotech sector with PEB, NYR, NOX and now IXC all having prangs. Market . Invex Therapeutics' Chief Scientific Officer, Professor Alexandra Sinclair, met with NASA's medical team. Created with Sketch. ASX - Day TradingA new thread to put trading comments / reasoning / opinions in. . Market . Click for more information. ASX - By Stock. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. Created with Sketch. ASX - Day Trading. Latest Posts. . IXC needs to be proactive and release a statement. ASX - Day Trading. 333334. Daily bounced well off support and now slowly creeping upId like to see a range develop now between say 18 - 23 before next bit of news, page-517. 9MB OEC: 22/11/2023 1:05 PM : Cleansing Notice 2 pages 172. All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool. Created with Sketch. This is a complete waste of time and posting space - give yourself a break man and forget about trying to predict what is completely un-predictable. 5¢ Sentiment: Hold Disclosure: Held IXC Valuation Report MST. ASX - General. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. Just a matter of time really. I see it at perhaps $5 prior to readout. . 31% more bullish than other Healthcare sector stocks. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. Created with Sketch. Forums. Share Would anyone know whether the 28c cash backing strips out all of the options listed in the notice? or is it included and they will fall away on strike dates?wonder if the GLP-1 agonist referred to in this media release. Latest Posts. 333334. Update - Notification regarding unquoted securities - IXC. Also took placement stock @$1. , page-75. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. . I knew zero about the fundamentals of IXC. Charts. Although, IXC is trading about 3-4x lower than what I expect it to be. ASX - General. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX. Target our investor community with our suite of Hotcopper Advertising opportunities. 00% 21. Notice of Annual General Meeting/Proxy Form, page-2. Just unfortunate to hit the black swan so badly here, both the. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. IXC Price at posting: 44. Most bio's get. 38 Biotechnology stocks are valued based on a risk. . Share. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumUK R&D Tax Rebate. Created with Sketch. But since the cash holding is double the market cap, there most likely more upside than down side. 76 (-1. We are a team of expert financial advisers each specialising in different, yet complementary areas. is 19. . But the market volume was very low, which points to a lack of interest, the long horizons of biotech, lack of publicising or Notification of cessation of securities - IXC. Created with Sketch. Advertise on HotCopper. ASX - Day TradingCreated with Sketch. Latest Posts. ASX - By Stock. Market open. , page-2. 6 Upvote. . I think having this out we can discuss on the way. A new thread to put trading comments / reasoning / opinions in. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. Australia's largest stock trading and investment forum Australia's #1 stock forumCreated with Sketch. ASX - Day Trading. Notice of Investor Call and Presentation, page-3. Created with Sketch. International Markets. A rolling snowball gathers snow as it falls down the hill . ASX - By Stock. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Created with Sketch. . 30 order I had out there for 2-3 weeks. . 0. Latest Posts. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. 3¢. ASX - Day TradingChange in substantial holding. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Created with Sketch. . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving. Only took that large seller to sell, now liquidity has dried up and. ASX - Day TradingIf anyone told me a year ago, "there is a chance IXC cant progress the trial and the management all get sacked" I would agree that there was a chance, but nullified to a 1-2% black swan and worth the upside return profile. I think IXC has the potential to do better. . ASX - By Stock. 19 Per share (Personal Estimate) vs MST Research report of $3. Appreciate your input Dr T. Created with Sketch. Loading. Created with Sketch. ASX - Short Term Trading. Maybe more common that what people think, imagine once GPs start diagnosing it even better if a treatment is developed, Prevalence could increase 2 or times which ultimately increases. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. , page-5. Discover historical prices for IXC. (IXC) - see HotCopper and other bloggers' predictions - TipRanks. You’d be surprised the volume that comes in when this happenes, but by that stage you’ll be 100% up whilst the opportunity cost traders will be trying to catch the move up. ASX - General. , page-2. With a team of 68. 0¢ Sentiment: Buy Disclosure: Held. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. Thought Id reshare as both now into phase 3 trials fully funded (please bare in mind 2. Market . 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. 20 to $7. Invex Therapeutics Lists on ASXNo worries mate :), page-15. , page-32. 15M !Invex to Present at Bell Potter Healthcare ConferenceNotice of Annual General Meeting/Proxy Form, page-3. . 6% $DLM 50. We are supported by a Board of Advice which is made up of the premier leaders in the various fields in which we, Private Capital Advisers, specialise. Andrew Forrest , or his entities have been involved with IXC since inception. Forums. $100-200k might be the minimum for the market to take notice. Anyone had a look at this or put an application in for some stock in the IPO?, page-2. ASX - Day TradingInvex Files Pre-IND/Type B Meeting Request with US FDA, page-2. ASX - General. View listing photos, review sales history, and use our detailed real estate filters to find the perfect place. . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. . 5% last year. ASX - By Stock. Access the latest research articles and market investment insight for INVEX THERAPEUTICS LTD seamlessly. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. . IXC Valuation Report MST. Anyone buying now can carry to $5 and then sell a few prior to readout as insurance against losing everything in the coin flip. Australia's largest stock trading and investment forum Australia's #1 stock forumMay 18 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX THERAPEUTICS SEEKS TRADING HALT PENDING RELEASE ON RESULTS OF ITS PHASE II TRIAL & UNDERTAKING A. Latest Posts. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentNotice of Annual General Meeting/Proxy Form. , page-3. So it seems that as of 18 July the trials are still recruiting! An update was submitted to this site 3 days. Created with Sketch. Orphan drug status. ASX - Short Term Trading. Postcard to ShareholdersIXC (ASX) Ann: Trading Halt - HotCopper. Advertise on HotCopper. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. 1. Latest Posts. Contrast that to data from Wales in 2017 which suggests that. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself,Publication of Invex IIH Phase II Pressure Trial Results. Latest Posts ForumsThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited) At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. ASX - General. . ASX - Day Trading. Join the HotCopper ASX share market forum today for free. Forums. , page-3. Created with Sketch. , page-5. TRP also trades sub cash -5m i believe, haven't checked in a while. Created with Sketch. 8 Upvote Created with Sketch. Share Ok news not the greatest but I dont think its as bad as people gonna re-act (mainly retailers) Primary endpoint remains unchanged Protocol changes focus on reordering secondary endpoints - replacing PMD with the more. 50%. Sentiment for Invex Therapeutics Ltd. Forums. Get the edge as an investor: Subscribe to our daily newsletter for EXCLUSIVE insights into HotCopper!. IXC could also be worth $14 on a successful trial and licensing deal (or takeover). . Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. wonder if the GLP-1 agonist referred to in this media release. 0¢ Sentiment: Buy Disclosure: Held Bumping up this thread as $3. ASX - By Stock. ASX - Day TradingHere's a very good opportunity for people in Sydney. How many friends and family got out after the last announcementshould have been released at the same time, page-34. AdINVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. IXC. ASX - General. Initial FDA and EMA Advice on Presendin Development, page-3. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. , page-4. Some people like to gamble on stocks, others invest. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentHREC and TGA Approval to Commence Phase 3 in AustraliaHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. 1. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. 0. I guess that's why retail performs so poorly on average, so many think they are long term investors but can't hold onto their shares for more. Latest Posts. Plus, the opportunity to explore other conditions, including hydrocephalus and meningitis. , page-3. 7% #asx #ausbiz 23 Jun 2023 06:06:11Not been following IXC but it seems that this Orphan Drug Designation for TBI now have $0 value due to the other Phase III trial update and the company is. Re-purposed FDA drug for other illness with amazing effect as domenstrated in P2 results which ever drove sp to $2. Forums. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Commodities. 1. 0 Great analysis. , page-4. Created with Sketch. Most bio's get acquired on P2 readouts, if results are strong early here. . Charts. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. ASX - By Stock. Thought that this would be worthy of its own thread, a great starting place for those new to IXC and arguably the best presentation to date, Worth a. Latest Posts. ASX - General. ASX - By Stock. Invex Files Pre-IND/Type B Meeting Request with US FDAIXC is a long term play mate, not a daytraders plaything as too illiquid. , page-6. Created with Sketch. Discover historical prices for IXC. Appendix 4C - quarterlyAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. 20. See page-34. Last updated 15. . Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited)At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Latest Posts. ASX - Short Term Trading. 2 Upvote. Can't see how this doesn't push up soon, page-508. Probably been disappointed like all of usCreated with Sketch. Both approaches can work, but it is not wise to confuse the two.